Nitric oxide in heart failure: Friend or foe

Heart Failure Reviews

Volumn 7, Issue 4, 2002, Pages 385-389

  Jugdutt, Bodh I ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Heart failure; Infarction; Ischemia; Nitric oxide; Nitroglycerin

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLYCERYL TRINITRATE; NITRATE; NITRIC OXIDE; NITRIC OXIDE DONOR; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; PEROXYNITRITE; SILDENAFIL;

ACUTE HEART INFARCTION; ANGINA PECTORIS; APOPTOSIS; AUTONOMIC NERVOUS SYSTEM FUNCTION; BLOOD CLOTTING DISORDER; BLOOD FLOW; BLOOD PRESSURE; BLOOD VESSEL; CARDIOVASCULAR DISEASE; CELL DEATH; CORONARY REPERFUSION; CYTOTOXICITY; DISEASE MODEL; DOSE RESPONSE; DRUG EFFECT; ERECTILE DYSFUNCTION; GENE THERAPY; HEART FAILURE; HEART HEMODYNAMICS; HEART PROTECTION; HUMAN; HYPERTENSION; HYPOTENSION; NITRATE METABOLISM; NONHUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; REVIEW; SEPSIS; STROKE; VASODILATATION; ARTICLE; CHEMISTRY; CONGESTIVE HEART FAILURE; PHYSIOLOGY; VASCULAR ENDOTHELIUM;

ANGINA PECTORIS; ENDOTHELIUM, VASCULAR; HEART FAILURE, CONGESTIVE; HUMANS; NITRIC OXIDE;

EID: 0036813663     PISSN: 13824147     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1020767731450     Document Type: Review

References (36)

1. Brunton TL. On the use of nitrate of amyl in angina pectoris. Lancet 1867;2:97-98.
2. Furchgott RF, Zawadski JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980;288:373-376.
3. Palmer RMJ, Ferrige AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987;327:524-526.
4. Ignarro LJ, Lippton H, Edwards JC, et al. Mechanism of vascular smooth muscle relaxation by organic nitrates, nitroprusside and nitric oxide: Evidence for the involvement of S-nitrosothiols as active intermediates. J Pharmacol Exp Ther 1981;218:739-749.
5. Ignarro LJ. Biosynthesis and metabolism of endothelium-derived nitric oxide. Annu Rev Pharmacol Toxicol 1990;30:535-560.
6. Moncada S, Palmer RM, Higgs EA. Nitric oxide: Physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991;43:109-142.
7. Luscher TF. Endogenous and exogenous nitrates and their role in myocardial ischemia. Br J Clin Pharmacol 1992;34(Suppl 1):29S-35S.
8. Culotta E, Korschland DE Jr. NO news is good news. Science 1992;258:1862-1865.
9. Stamler JS, Singel DJ, Loscalzo J. Biochemistry of nitric oxide and its redox-activated forms. Science 1992;258:1898-1902.
10. Radomski MW, Palmer RM, Moncada S. The anti-aggregating properties of vascular endothelium: Interaction between prostacyclin and nitric oxide. Br J Pharmacol 1987;92:639-646.
11. Radomski MW, Palmer RM, Moncada S. An l-arginine/nitric oxide pathway present in human platelets regulates aggregation. Proc Natl Acad Sci USA 1990;87:5193-5197.
12. Vila-Petroff MG, Younes A, Egan J, Lakatta EG, Sollott SJ. Activation of distinct cAMP-dependent and cGMP-dependent pathways by nitric oxide in cardiac myocytes. Circ Res 1999;84:1020-1031.
13. Recchia FA, McConnell PI, Bernstein RD, Vgel TR, Xu X, Hintze TH. Reduced nitric oxide production and altered myocardial metabolism during the decompensation of pacing-induced heart failure in the conscious dog. Circ Res 1998;83:969-979.
14. Murell W. Nitroglycerin as a remedy for angina pectoris. Lancet 1879;1:80-81, 113-115, 115-122, 225-227.
15. Jugdutt BI. Myocardial salvage by intravenous nitroglycerin in conscious dogs: Loss of beneficial effect with marked nitroglycerin-induced hypotension. Circulation 1983;68:673-684.
16. Jugdutt BI, Warnica JW. Intravenous nitroglycerin therapy to limit myocardial infarct size, expansion and complications. Effect of timing, dosage and infarct location. Circulation 1988;78:906-919.
17. Jugdutt BI, Warnica JW. Tolerance with low dose intravenous nitroglycerin therapy in acute myocardial infarction. Am J Cardiol 1989;64:581-587.
18. Jugdutt BI. Intravenous nitroglycerin unloading in acute myocardial infarction. Am J Cardiol 1991;68:52D-62D.
19. Stewart DD. Remarkable tolerance to nitroglycerine. Philadelphia Polyclinic 1888;6:43.
20. Prodger SH, Ayman D. Harmful effects of nitroglycerin: With special reference to coronary thrombosis. Am J Med Sci 1932;184:480-491.
21. Imhof PR, Ott B, Frankhauser P, Chu LC, Hodler J. Difference in nitroglycerin dose-response in the venous and arterial beds. Eur J Clin Pharmacol 1980;18:455-460.
22. Jugdutt BI. Nitrates in myocardial infarction. Cardiovasc Drugs Ther 1994;8:635-616.
23. Fye WB. Nitroglycerin: A homeopathic remedy. Circulation 1983;73:21-29.
24. Siegfried MR, Erhardt J, Rider T, Ma XL, Lefer AM. Cardioprotection and attenuation of endothelial dysfunction by organic nitric oxide donors in myocardial ischemia-reperfusion. J Pharmacol Exp Ther 1992;260:668-675.
25. Johnson G 3rd, Tsao PS, Lefer AM. Cardioprotective effects of authentic nitric oxide in myocardial ischemia with reperfusion. Crit Care Med 1991;19:244-252.
26. Keefer LK. Nitric oxide-releasing compounds: From basic research to promising drugs. Mod Drug Discov 1998;1:20-30.
27. Hare JM, Givertz MM, Creager MA, Colucci WS. Increased sensitivity to nitric oxide synthase inhibition in patients with heart failure. Potentiation of β-adrenergic inotropic responsiveness. Circulation 1998;97:161-166.
28. Andrews KL, Triggle CR, Ellis A. NO in the vasculature: Where does it come from and what does it do? Heart Fail Rev 2002;7:423-445.
29. Paulus WJ, Bronzwaer JGF. Myocardial contractile effects of nitric oxide. Heart Fail Rev 2002;7:371-383.
30. Wollert K, Drexler H. Regulation of cardiac remodeling by nitric oxide: Focus on cardiac myocyte hypertrophy and apoptosis. Heart Fail Rev 2002;7:317-325.
31. Oyama J, Frantz S, Blais C, Kelly RA, Bourcier T. Nitric oxide, cell death, and heart failure. Heart Fail Rev 2002;7:327-334.
32. Mungrue IN, Hussain M, Stewart DJ. The role of NOS in heart failure: Lessons from murine genetic models. Heart Fail Rev 2002;7:407-422.
33. Lalu MM, Wang W, Schultz R. Peroxynitrite in myocardial ischemia-reperfusion injury. Heart Fail Rev 2002;7:359-369.
34. de Gasparo M. Angiotensin II and nitric oxide interaction. Heart Fail Rev 2002;7:347-358.
35. Warnholtz A, Tsilimingas N, Wendt M, Munzel T. Mechanisms underlying nitrate-induced endothelial dysfunction: Insight from experimental and clinical studies. Heart Fail Rev 2002;7:335-345.
36. Jugdutt B. NO and cardioprotection during ischemia-reperfusion. Heart Fail Rev 2002;7:391-405.